Quick10K

⚲

Ocean Bio Chem

Filings

10-Q	2021-03-31	Filed 2021-05-14
10-K	2020-12-31	Filed 2021-03-29
10-Q	2020-09-30	Filed 2020-11-13
10-Q	2020-06-30	Filed 2020-08-14
10-Q	2020-03-31	Filed 2020-05-15
10-K	2019-12-31	Filed 2020-03-30
10-Q	2019-09-30	Filed 2019-11-14
10-Q	2019-06-30	Filed 2019-08-14
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-03-29
10-Q	2018-09-30	Filed 2018-11-14
10-Q	2018-06-30	Filed 2018-08-14
10-Q	2018-03-31	Filed 2018-05-15
10-K	2017-12-31	Filed 2018-03-30
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-14
10-Q	2017-03-31	Filed 2017-05-15
10-K	2016-12-31	Filed 2017-03-31
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-03-30
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-14
10-Q	2015-03-31	Filed 2015-05-15
10-K	2014-12-31	Filed 2015-03-31
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-08-14
10-Q	2014-03-31	Filed 2014-05-15
10-K	2013-12-31	Filed 2014-03-31
10-Q	2013-09-30	Filed 2013-11-14
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-15
10-K	2012-12-31	Filed 2013-04-01
10-Q	2012-09-30	Filed 2012-11-14
10-Q	2012-06-30	Filed 2012-08-14
10-Q	2012-03-31	Filed 2012-05-15
10-K	2011-12-31	Filed 2012-03-30
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-13
10-K	2010-12-31	Filed 2011-03-31
10-Q	2010-09-30	Filed 2010-11-12
10-Q	2010-06-30	Filed 2010-08-13
10-Q	2010-05-13	Filed 2010-05-13
10-K	2009-12-31	Filed 2010-03-30

Reports

8-K	2020-11-23
8-K	2020-09-19
8-K	2020-08-26
8-K	2020-08-10
8-K	2020-07-17
8-K	2020-05-29
8-K	2020-05-26
8-K	2020-05-15
8-K	2020-04-27
8-K	2020-04-27
8-K	2020-03-19
8-K	2020-01-28
8-K	2019-11-14
8-K	2019-08-14
8-K	2019-06-03
8-K	2019-03-22
8-K	2018-11-14
8-K	2018-08-31
8-K	2018-08-14
8-K	2018-08-06
8-K	2018-05-18
8-K	2018-05-15
8-K	2018-04-26
8-K	2018-03-30
8-K	2018-03-19
8-K	2018-01-17

Ocean Bio Chem Financials

OBCI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	539	809	585	685	1,128	775	1,508	534	1,006	679	3,072	2,830	2,714	1,828	3,063	2,012	2,847	933	2,468	2,436	1,796	1,086	4,070	3,399	868	3,434	2,747	5,050	3,688	4,398	3,734	2,727	3,287	3,986
Accounts Receivable	3,510	5,487	2,563	3,051	2,964	5,912	2,931	3,206	3,868	6,881	4,414	2,968	4,217	6,154	4,850	3,482	4,012	7,607	5,092	4,090	5,566	9,414	4,932	4,779	6,248	8,454	4,964	5,003	9,072	10,792	5,659	6,693	8,554	10,254
Inventory	9,184	10,660	9,628	9,935	9,145	9,535	9,257	10,087	9,690	8,598	7,368	8,764	7,950	8,794	8,109	10,097	9,105	9,377	7,915	9,066	8,800	8,955	8,601	10,166	10,209	10,124	9,074	9,968	10,134	11,653	12,086	12,525	11,683	11,408
PP&E	5,298	5,215	5,213	5,141	13,406	13,541	13,861	13,980	14,189	14,336	14,373	14,517	14,810	15,009	15,090	15,371	15,771	15,946	16,098	16,137	16,217	16,286	16,472	17,376	18,964	19,993	21,711	22,287	22,632	22,891	23,070	23,329	23,454	23,552
Assets	20,206	23,974	19,879	20,581	20,279	23,188	21,010	21,321	21,797	23,668	22,243	22,559	22,764	24,476	23,980	24,185	24,229	25,997	23,989	24,163	24,311	27,210	25,671	27,517	27,278	34,399	31,991	32,857	35,493	40,583	35,235	36,670	37,189	39,134
Accounts Payable	1,055	2,712	1,162	1,321	1,577	2,275	1,431	1,556	1,591	2,266	1,014	1,491	1,348	2,397	1,440	1,996	1,410	2,618	1,102	2,119	1,787	2,994	1,512	2,547	2,230	2,776	1,807	1,929	2,546	3,409	1,472	1,587	1,481	2,541
Long-Term Debt	2,498	2,440	2,340	2,240	1,737	1,997	1,902	1,806	1,709	1,611	1,513	1,413	1,313	1,212	1,110	1,007	903	798	692	585	478	369	260	149	41	4,165	4,082	4,020	3,959	4,622	4,514	4,419	4,309	4,202
Liabilities	7,592	10,212	5,845	6,171	5,194	7,324	4,580	4,560	4,553	5,709	3,971	4,451	3,913	4,949	3,948	4,177	4,105	5,421	3,345	4,577	4,071	5,145	3,156	4,499	3,839	9,822	7,095	7,997	9,497	13,024	7,801	8,974	8,469	9,050
Stockholders' Equity	12,307	13,465	13,751	14,139	14,822	15,610	16,176	16,528	17,020	17,727	18,044	17,886	18,635	19,528	20,032	20,008	20,124	20,576	20,644	19,586	20,240	22,065	22,515	23,017	23,439	24,577	24,896	24,861	25,995	27,559	27,433	27,696	28,720	30,084


Income Statement ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	8,218	9,884	6,847	6,005	7,882	10,262	490	6,312	8,178	10,441	7,773	5,921	8,813	10,432	8,761	6,002	8,739	10,837	8,410	6,750	8,724	12,207	581	8,392	9,903	11,652	545	8,384	11,399	13,182		9,081	10,945	12,503
Cost of Revenue	5,240	6,538	4,995	3,863	10	10	10	10	10	10	10	10	10	10	10	10	10	7,274	10	4,368	5,053	7,307	10	5,257	5,624	7,542	6,013	5,406	6,745	8,671		5,660	6,428	8,097
Gross Profit	2,978	3,346	1,852	2,142	2,865	3,264	2,356	2,241	2,972	3,182	2,493	2,088	3,431	3,593	3,018	2,037	3,164	3,562	2,577	2,382	3,671	4,900	2,921	3,135	4,278	4,110	2,974	2,978	4,654	4,511		3,421	4,517	4,406
R&D																													10	10
SG&A	1,674	1,241	972	1,056	1,604	1,306	1,161	1,150	1,879	1,552	1,348	1,152	2,132	1,615	1,641	1,422	2,057	2,351	1,750	2,486	1,794	1,911	1,469	1,544	1,984	2,011	1,759	1,555	2,289	2,109		1,700	2,212	2,149
Tax	224	479	76	386	446	389	140	179	92	351	194	130	168	426	232	87	53	144	53	0	346	674	248	236	617	529	125	156	364	358		209	285	319
Net Income	389	1,138	217	364	363	771	464	349	173	629	318	224	411	903	511	-16	114	296	67	-541	657	1,528	451	504	953	854	293	523	1,121	1,272		715	1,010	1,125


Cash Flow ($'000)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-397	2,524	-410	1,758	-1,411	2,838	-752	784	-298	2,832	-3	717	-423	1,495	-605	1,246	-1,625	1,785	138	96	-497	3,289	363	-245			522	-1,498	-180		-606	865	1,329
Cash Investing		-70	-159	-90	-139	-145	-396	-119	-209	-307	-37	-183	-293	-349	-155	-316	-306	-180	-152	-76	-81	-101	-186	-905	-1,629			-572	-344	-641		-304	-125	-98
Cash Financing		741	-2,591	600	-1,173	1,200	-1,708	-101	-102	278	-403	-40	-543	-103	-104	-105	-110	-112	-111	-91	-653	-113	-121	-117	-664			-66	480	1,530		-98	-180	-533